VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 145 participants.
Also called NCT04414878
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 145 participants
- Registry
-
NCT04414878
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04414878. Allocation not applicable; no masking; primary purpose treatment. Start 2018-01-31 (actual); primary completion 2022-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial
- Condition
- Aortic Stenosis
- Intervention (Device)
- VitaFlow™ II Transcatheter Aortic Valve System
- Lead sponsor
- Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Record details
- Record id
cardio:ct-nct04414878- Content hash
7b28be167d03e9b2b26117282512c4fcbc091c3c2b6177bc924eb53dce86b25f